Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Spectrum Pharma Inc
(NQ:
SPPI
)
1.030
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 31, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Spectrum Pharma Inc
< Previous
1
2
3
4
5
6
7
8
Next >
CLASS ACTION UPDATE for BLCT, ATVI and SPPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
September 03, 2021
NEW YORK, NY / ACCESSWIRE / September 3, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....
From
Levi & Korsinsky, LLP
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
SHAREHOLDER ALERT: ITRM SESN SPPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
September 03, 2021
NEW YORK, NY / ACCESSWIRE / September 3, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered...
From
The Law Offices of Vincent Wong
Via
AccessWire
Topics
Fraud
Exposures
Legal
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of JRVR, CRMD and SPPI
September 02, 2021
NEW YORK, NY / ACCESSWIRE / September 2, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded...
From
The Gross Law Firm
Via
AccessWire
SPECTRUM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
September 02, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
CLASS ACTION UPDATE for ATVI, SLQT and SPPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
September 02, 2021
NEW YORK, NY / ACCESSWIRE / September 2, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....
From
Levi & Korsinsky, LLP
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) on Behalf of Investors
September 02, 2021
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) on Behalf of Investors
September 02, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LIVE, SLQT and SPPI
September 02, 2021
NEW YORK, NY / ACCESSWIRE / September 2, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...
From
The Klein Law Firm
Via
AccessWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) on Behalf of Investors
September 02, 2021
From
Law Offices of Howard G. Smith
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 02, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 01, 2021
From
The Schall Law Firm
Via
Business Wire
SPPI ALERT: Investors With Substantial Losses Have Opportunity to Lead the Spectrum Pharmaceuticals, Inc. Class Action Lawsuit
September 01, 2021
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SPPI
September 01, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
Have You Lost Money Investing In Spectrum Pharmaceuticals? Securities Class Action Investigation -SPPI Investors Who Have Suffered Financial Losses Encouraged To Contact Kehoe Law Firm, P.C.
September 01, 2021
PHILADELPHIA, PA / ACCESSWIRE / September 1, 2021 / Kehoe Law Firm, P.C. is investigating whether Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ:SPPI) violated federal securities...
From
Kehoe Law Firm, P.C.
Via
AccessWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Investor Notice: Investigation over Possible Securities Laws Violations
August 17, 2021
San Diego, CA -- (SBWIRE) -- 08/17/2021 -- Spectrum Pharmaceuticals, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Spectrum Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Update
August 12, 2021
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
SPECTRUM ALERT: Bragar Eagel & Squire, P.C. is Investigating Spectrum Pharmaceuticals, Inc. on Behalf of Spectrum Stockholders and Encourages Investors to Contact the Firm
August 10, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS® (eflapegrastim)
August 06, 2021
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Corporate Update
August 05, 2021
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals Presents Poziotinib Data in Patients with Brain Metastases from the ZENITH20 Clinical Trial at 2021 ASCO Annual Meeting
June 04, 2021
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals Announces That the ROLONTIS® (eflapegrastim) Pre-Approval Inspection Has Been Initiated
June 01, 2021
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals to Present Data for Poziotinib in Patients with Brain Metastases at the Upcoming 2021 ASCO Annual Meeting
May 28, 2021
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences in June
May 27, 2021
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals Reports First Quarter 2021 Financial Results and Corporate Update
May 13, 2021
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals to Report First Quarter 2021 Financial Results and Provide Corporate Update
May 06, 2021
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals Presents Additional Twice Daily Dosing Data for Poziotinib at the AACR Virtual Meeting 2021
April 10, 2021
From
Spectrum Pharmaceuticals
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.